American Society of Hematology

SHERPA: Blue

People

  1. Dogan
    Dogan
  2. Horwitz
    Horwitz
  3. Zelenetz
    Zelenetz
  4. Moskowitz
    Moskowitz
  5. Palomba
    Palomba
  6. Kumar
    Kumar
  7. Noy
    Noy
  8. Hamlin
    Hamlin
  9. Lesokhin
    Lesokhin
  10. Levine
    Levine

Groups

  1. Department of Medicine (113)
  2. Hematologic Malignancies, Division of (113)
  3. Center for Hematologic Malignancies (111)
  4. Lymphoma (69)
  5. Sloan Kettering Institute Postdocs (60)
  6. Survivorship Research (57)
  7. Population Sciences Research Program (52)
  8. GSK Faculty (51)
  9. Epidemiology and Biostatistics (49)
  10. Executive Committee, Center for Hematologic Malignancies (46)
Search Within
  1. "Ahmet Dogan"
Formats
  1. Meeting Abstract (99)
  2. Journal Article (26)
  3. Research Letter (2)
  4. Guidelines (1)
Groups
  1. Department of Medicine (113)
  2. Hematologic Malignancies, Division of (113)
  3. Center for Hematologic Malignancies (111)
  4. Lymphoma (69)
  5. Sloan Kettering Institute Postdocs (60)
  6. Survivorship Research (57)

More Groups

People
  1. Ahmet Dogan (128)
  2. Andrew Zelenetz (41)
  3. Steven Horwitz (41)
  4. Alison Moskowitz (40)
  5. Maria Palomba (31)
  6. Anita Kumar (29)

More People

Years
  1. 2023 (15)
  2. 2022 (15)
  3. 2021 (16)
  4. 2020 (13)
  5. 2019 (16)
  6. 2018 (8)

More Years

Publications
  1. Blood (117)
  2. Blood Advances (11)

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Deep learning for morphology-based, bone marrow cell classification
    Meeting Abstract

    Sun, S.; Cleave, J.; Wang, L.; Lucas, F.; Brown, L.; Spector, J.; Boiocchi, L.; Baik, J.; Zhu, M.; Ardon, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Journal Article

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Polytypic B-cells, B-cell lymphoproliferative disorders/lymphomas, and neoplastic T-cells divergently differentiate from TET2-/ DNMT3A-mutated clonal hematopoiesis in patients with follicular helper T-cell lymphomas/lymphoproliferative disorders
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Sardana, R.; Gao, Q.; Sethi, S.; Xiao, W.; Roshal, M.; Baik, J.; Bhurtel, H.; Moskowitz, A.; more...
    Blood (2023)

    Fulltext@MSK | Save